Vaccine "Neutralises" Key Mutation In UK, South Africa Virus Strains: BioNTech

German company BioNTech said Friday a preliminary study shows that its vaccine works against the key mutation in coronavirus variants uncovered in Britain and South Africa which experts have said is more contagious than the original Covid-19 strain.

Tests carried out have shown that "antibodies from people who have received the Pfizer-BioNTech COVID-19 vaccine effectively neutralise SARS-CoV-2 with a key mutation that is also found in two highly transmissible strains," said the German company of the vaccine it developed with US group Pfizer.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)